Exercise Interventions for Improving Eye Control Post Strabismus Surgery

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05303779
Collaborator
(none)
40
2
4

Study Details

Study Description

Brief Summary

The purpose of this study will be focused on the following issue:
  1. The aim of this study is to determine therapeutic effect of postoperative eye exercises on improving eye control after the strabismus surgery.
HYPOTHESES:
It will be hypothesized that:

• Eye exercises have a positive effect on improving eye control post strabismus surgery.

RESEARCH QUESTION:"

• Do postoperative eye exercises improve eye control post strabismus surgery?

Condition or Disease Intervention/Treatment Phase
  • Other: Exercise Interventions of Eye Muscles
  • Drug: Medication and eye glasses
N/A

Detailed Description

Therapeutic procedures:
  • Patient will be informed about measurement and treatment procedure before beginning of the treatment.

  • Patient will be asked to follow physician instructions.

  • Patients will be asked to avoid participation in any rehabilitation program prior to the study which may affect the result of the study.

  • Measurement procedures will be applied for each patient.

  • They will start the treatment program after 2 weeks of the surgery.

The subjects will be divided into two groups (experimental group and control group) with equal numbers of patients in each group:

Control group Participants within the control group will receive traditional care and medication following strabismus surgery.

Experimental group Participants within the experimental group will receive physiotherapy exercises beside traditional care and medication after strabismus surgery. Physical therapy exercises will apply in the office and home. Office exercises will involve palming exercise, pencil push-ups, brock string exercise, thumb exercise (Near-distance jump), balance board exercise, Proprioceptors Neuromuscular Facilitating (PNF) exercise, occlusive therapy, eye hand coordination and computer therapy. Office exercises will be done two sessions per week for three months. Each session will be about 1 hour. Exercises will also perform at home from the first session including eye exercises in all directions, pencil push-ups, thumb exercise (Near-distance jump),brock string exercise, and dominant eye occlusion for 1 hour daily.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Exercise Interventions of Eye Muscles for Improving Eye Control Post Strabismus Surgery
Anticipated Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Jul 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: experimental group

experimental group will receive eye exercises in addition to medication and eye glasses post strabismus surgery

Other: Exercise Interventions of Eye Muscles
Application of eye exercise for improving eye control post strabismus surgery
Other Names:
  • experimental
  • Drug: Medication and eye glasses
    medication and eye glasses used post strabismus surgery
    Other Names:
  • control
  • Active Comparator: control group

    control group will receive medication and eye glasses post strabismus surgery

    Drug: Medication and eye glasses
    medication and eye glasses used post strabismus surgery
    Other Names:
  • control
  • Outcome Measures

    Primary Outcome Measures

    1. changing in eye control [before the treatment and after 12 weeks (at the end of the treatment period )]

      The level of control will be evaluated in each patient at both distance and near fixation using Intermittent Exotropia Control Scale. Fixation targets will be at 3 meters for distance fixation and it will be at 33 centimeters for near fixation. Intermittent Exotropia Control Scale 5 = Constant exotropia 4 = Exotropia > 50% of the exam before dissociation 3 = Exotropia < 50% of the exam before dissociation 2 = No exotropia unless dissociated, recovers in > 5 seconds 1 = No exotropia unless dissociated, recovers in 1-5 seconds 0 = No exotropia unless dissociated, recovers in < 1 second (phoria) The scale ranges from 0 (phoria, best control) to 5 (constant exotropia, worst control).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 15 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Criteria of selecting the patients include the following:

    • Patients are both males and females.

    • Their age will range from (5-15) years.

    • Patients received strabismus operation.

    • They will be selected from Outpatient Clinic of Research Institute of Ophthalmology.

    • Patients will begin the training program after 2 weeks of operation.

    • All types of strabismus surgery will be included.

    Exclusion Criteria:

    The subjects will be excluded from the study if they meet one of the following criteria;

    • Muscular disorders that will impair performance during training.

    • Any organic lesion in the eye.

    • Neurological disorders.

    • Malignant conditions.

    • Psychiatric illness, severe behavior or cognitive disorders.

    • Children who can't understand the therapist's instructions and orders.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Amany Refaat Mohamed Abdel Wahid, principle investigator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05303779
    Other Study ID Numbers:
    • P.T.REC/012/003505
    First Posted:
    Mar 31, 2022
    Last Update Posted:
    Mar 31, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 31, 2022